共 50 条
- [1] DOSE-RANGING ANTIEMETIC TRIAL OF HIGH-DOSE ORAL METOCLOPRAMIDE [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (03): : 239 - 243
- [2] ANTIEMETIC EFFECT OF HIGH-DOSE METOCLOPRAMIDE [J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (03) : 440 - 441
- [4] LACK OF ANTIEMETIC EFFECT OF HIGH-DOSE METOCLOPRAMIDE [J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (09) : 1273 - 1276
- [6] ANTIEMETIC PROPHYLAXIS WITH HIGH-DOSE METOCLOPRAMIDE OR LORAZEPAM IN VOMITING INDUCED BY CHEMOTHERAPY [J]. BRITISH MEDICAL JOURNAL, 1984, 288 (6434): : 1879 - 1879
- [8] HIGH-DOSE METOCLOPRAMIDE, DEXAMETHASONE AND LORAZEPAM - AN EFFECTIVE ANTIEMETIC COMBINATION IN THE MANAGEMENT OF CYTOTOXIC INDUCED NAUSEA AND VOMITING [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1987, 15 (03): : 152 - 152
- [10] PARKINSONISM FOLLOWING IV ADMINISTRATION OF HIGH-DOSE METOCLOPRAMIDE USED AS AN ANTIEMETIC AGENT DURING CANCER-CHEMOTHERAPY [J]. CANCER TREATMENT REPORTS, 1985, 69 (03): : 341 - 342